Gene · 1942
Papers1,708
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 1,708
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Integrative single-cell and exosomal multi-omics uncovers SCNN1A and EFNA1 as non-invasive biomarkers and drivers of ovarian cancer metastasis. | Front Immunol | 2025 | 40787466 | PubTator, text mining | PubMed |
| Mechanism Study on Inhibition of EPHA2 Expression Impaired Skin Barrier Function by Gefitinib. | Exp Dermatol | 2025 | 40734331 | PubTator, text mining | PubMed |
| Cancer genome profiling of prostate cancer identifies a patient with a novel EFNA1-NTRK1 fusion gene. | Int Cancer Conf J | 2025 | 40625757 | PubTator, text mining | PubMed |
| Molecular mechanism of secretory protein EFNA1 in HNSCC and its value in early screening. | Biochem Biophys Res Commun | 2025 | 40578286 | PubTator, text mining | PubMed |
| Unraveling the power of radiomics: prediction and exploration of lymph node metastasis in stage T1/2 esophageal squamous cell carcinoma. | NPJ Precis Oncol | 2025 | 40523899 | PubTator, text mining | PubMed |
| Twin Study Provides Heritability Estimates for 2321 Plasma Proteins and Assesses Missing SNP Heritability. | J Proteome Res | 2025 | 40425507 | PubTator, text mining | PubMed |
| Comprehensive analysis of potential biomarkers for the diagnosis and prognosis of Cervical squamous cell carcinoma - based on GEO and TCGA databases. | Front Oncol | 2025 | 40406253 | PubTator, text mining | PubMed |
| The RNA-Binding Proteins MCPIP2 and IGF2BP1 Competitively Modulate Breast Tumor Angiogenesis by Antagonizing VEGFA mRNA Stability and Expression. | FASEB J | 2025 | 40354028 | PubTator, text mining | PubMed |
| Blood toxicogenomics reveals potential biomarkers for management of idiosyncratic drug-induced liver injury. | Front Genet | 2025 | 40201567 | PubTator, text mining | PubMed |
| Cholesterol inhibits assembly and oncogenic activation of the EphA2 receptor. | Commun Biol | 2025 | 40069393 | PubTator, text mining | PubMed |
| Differential association of EphA2 intracellular regions in biased signaling. | J Biol Chem | 2025 | 40049409 | PubTator, text mining | PubMed |
Genetic Variants in RASSF1 (rs2073498), SERPINE1 (rs1799889), and EFNA1 (rs12904) Are Associated with Susceptibility in Mexican Patients with Colorectal Cancer: Clinical Associations and Their Analysis In Silico. | Genes (Basel) | 2025 | 40004552 | PubTator, text mining | PubMed |
| EFNA1 promotes the tumorigenesis and metastasis of cervical cancer by phosphorylation pathway and epithelial-mesenchymal transition. | Acta Histochem | 2025 | 39999525 | PubTator, text mining | PubMed |
| Super-enhancer-driven EFNA1 fuels tumor progression in cervical cancer via the FOSL2-Src/AKT/STAT3 axis. | J Clin Invest | 2025 | 39964764 | PubTator, text mining | PubMed |
| Ephrin-Eph signaling: an important regulator of epithelial integrity and barrier function. | Tissue Barriers | 2025 | 39921660 | PubTator, text mining | PubMed |
| Retraction Note: Comment on, "Increased expression of ephrin A1 in brain arteriovenous malformation: DNA microarray analysis". | Neurosurg Rev | 2025 | 39865188 | PubTator, text mining | PubMed |
| Ephrin A1 functions as a ligand of EGFR to promote EMT and metastasis in gastric cancer. | EMBO J | 2025 | 39838173 | PubTator, text mining | PubMed |
| Ephrin A1 Stimulates CCL2 Secretion to Facilitate Premetastatic Niche Formation and Promote Gastric Cancer Liver Metastasis. | Cancer Res | 2025 | 39412948 | PubTator, text mining | PubMed |
| The diagnostic value of serum Ephrin-A1 in patients with colorectal cancer. | Sci Rep | 2024 | 39732744 | PubTator, text mining | PubMed |
| Proteome-Wide Mendelian Randomization Analysis to Identify Potential Plasma Biomarkers and Therapeutic Targets for Epithelial Ovarian Cancer Subtypes. | Int J Womens Health | 2024 | 39726690 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1942/papers?page=3